121 related articles for article (PubMed ID: 8875085)
1. Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients.
Marfella R; Acampora R; Verrazzo G; Ziccardi P; De Rosa N; Giunta R; Giugliano D
Diabetes Care; 1996 Sep; 19(9):934-9. PubMed ID: 8875085
[TBL] [Abstract][Full Text] [Related]
2. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
Giugliano D; Marfella R; Acampora R; Giunta R; Coppola L; D'Onofrio F
Diabetes Care; 1998 Apr; 21(4):631-6. PubMed ID: 9571355
[TBL] [Abstract][Full Text] [Related]
3. The vascular effects of L-Arginine in humans. The role of endogenous insulin.
Giugliano D; Marfella R; Verrazzo G; Acampora R; Coppola L; Cozzolino D; D'Onofrio F
J Clin Invest; 1997 Feb; 99(3):433-8. PubMed ID: 9022076
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients.
Marfella R; Nappo F; De Angelis L; Paolisso G; Tagliamonte MR; Giugliano D
Diabetes Care; 2000 May; 23(5):658-63. PubMed ID: 10834426
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of glibenclamide and metformin on ambulatory blood pressure and cardiovascular reactivity in NIDDM.
Sundaresan P; Lykos D; Daher A; Diamond T; Morris R; Howes LG
Diabetes Care; 1997 May; 20(5):692-7. PubMed ID: 9135928
[TBL] [Abstract][Full Text] [Related]
6. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia.
Giugliano D; Marfella R; Coppola L; Verrazzo G; Acampora R; Giunta R; Nappo F; Lucarelli C; D'Onofrio F
Circulation; 1997 Apr; 95(7):1783-90. PubMed ID: 9107164
[TBL] [Abstract][Full Text] [Related]
7. L-arginine for testing endothelium-dependent vascular functions in health and disease.
Giugliano D; Marfella R; Verrazzo G; Acampora R; Nappo F; Ziccardi P; Coppola L; D'Onofrio F
Am J Physiol; 1997 Sep; 273(3 Pt 1):E606-12. PubMed ID: 9316452
[TBL] [Abstract][Full Text] [Related]
8. Effect of insulin on blood rheology in non-diabetic subjects and in patients with Type 2 diabetes mellitus.
Coppola L; Verrazzo G; La Marca C; Ziccardi P; Grassia A; Tirelli A; Giugliano D
Diabet Med; 1997 Nov; 14(11):959-63. PubMed ID: 9400920
[TBL] [Abstract][Full Text] [Related]
9. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM
Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
[TBL] [Abstract][Full Text] [Related]
10. Abnormal rheologic effects of glyceryl trinitrate in patients with non-insulin-dependent diabetes mellitus and reversal by antioxidants.
Giugliano D; Marfella R; Verrazzo G; Acampora R; Donzella C; Quatraro A; Coppola L; D'Onofrio F
Ann Intern Med; 1995 Sep; 123(5):338-43. PubMed ID: 7625621
[TBL] [Abstract][Full Text] [Related]
11. Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance.
Dorella M; Giusto M; Da Tos V; Campagnolo M; Palatini P; Rossi G; Ceolotto G; Felice M; Semplicini A; Del Prato S
J Clin Endocrinol Metab; 1996 Apr; 81(4):1568-74. PubMed ID: 8636369
[TBL] [Abstract][Full Text] [Related]
12. Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM.
Jeppesen J; Zhou MY; Chen YD; Reaven GM
Diabetes Care; 1994 Oct; 17(10):1093-9. PubMed ID: 7821127
[TBL] [Abstract][Full Text] [Related]
13. Metformin decreases blood pressure and obesity in OLETF rats via improvement of insulin resistance.
Kosegawa I; Katayama S; Kikuchi C; Kashiwabara H; Negishi K; Ishii J; Inukai K; Oka Y
Hypertens Res; 1996 Mar; 19(1):37-41. PubMed ID: 8829822
[TBL] [Abstract][Full Text] [Related]
14. The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review.
Wulffelé MG; Kooy A; de Zeeuw D; Stehouwer CD; Gansevoort RT
J Intern Med; 2004 Jul; 256(1):1-14. PubMed ID: 15189360
[TBL] [Abstract][Full Text] [Related]
15. Metformin: effects on cardiovascular risk factors in patients with non-insulin-dependent diabetes mellitus.
Palumbo PJ
J Diabetes Complications; 1998; 12(2):110-9. PubMed ID: 9559489
[TBL] [Abstract][Full Text] [Related]
16. Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM.
Westerveld HT; de Graaf JC; van Breugel HH; Akkerman JW; Sixma JJ; Erkelens DW; Banga JD
Diabetes Care; 1993 May; 16(5):683-8. PubMed ID: 8495604
[TBL] [Abstract][Full Text] [Related]
17. Effect of oral antidiabetic agents on plasma amylin level in patients with non-insulin-dependent diabetes mellitus (type 2).
Zapecka-Dubno B; Czyzyk A; Dworak A; Bak MI
Arzneimittelforschung; 1999 Apr; 49(4):330-4. PubMed ID: 10337452
[TBL] [Abstract][Full Text] [Related]
18. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
20. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.
Toft-Nielsen MB; Madsbad S; Holst JJ
Diabetes Care; 1999 Jul; 22(7):1137-43. PubMed ID: 10388979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
